Axsome Therapeutics Investor Relations Material

Axsome Therapeutics, Inc. is a biopharmaceutical company engaged in the development of novel therapies for central nervous system disorders. The Company focuses on the development of drugs for treating complex psychiatric and pain conditions providing alternatives to approved therapies that have been shown to be limited by adverse side effects, poor efficacy and other characteristics. The company focuses on the development of small molecules, which are designed to enhance memory and cognition by modulating cortisol receptor binding in the brain.